Are you an innovator active in the field of Organ-on-a-Chip (OoC) technology and Organoids? Are you curious about developments at the heart of the worlds most innovative biotech hub? In the fall of 2026, the Organ-on-Chip & Organoids innovation mission to Boston will take place. This is your chance to gain insight into the rapid developments and investments in Boston in OoC technologies, a fast-growing industry transforming drug development, disease modeling, and personalized medicine.

Are you interested in this innovation mission? Then express your interest and be the first to hear when registration opens.  

Interesting for you?

The mission is intended for entrepreneurs, researchers, engineers, clinicians, ethicists, business developers, and anyone connected to a knowledge institution, academic hospital, technology company, or patient organization. Are you active in OoC technologies and organoids and interested in trans-Atlantic connections to further develop your research or solutions? Then this innovation mission may be interesting for you.

What can you expect

The mission brings together experts from both the Dutch and American ecosystems to:

  • connect;
  • explore research and development opportunities;
  • and collaborate on the further development of OoC technologies. 

Together, we want to build a new industrial sector focused on improving patient outcomes. Participation in the mission provides insights into opportunities for trans-Atlantic collaboration.

Why Boston?

Boston (Massachusetts) is a world leader in Life Sciences and the health sector. From research and development to entrepreneurship and commercialization: Boston leads in biotechnology, largely thanks to the supportive ecosystem of government, companies, universities, venture capital, and entrepreneurs. Moreover, the partnership (both MoU and collaboration program in Life Sciences & Health) between Massachusetts and the Netherlands is unique: there is no other formalized agreement between the government of Massachusetts and another country that is comparable. The core of this partnership is improving patients lives and it remains relevant and successful thanks to the dedication of both parties to this trans-Atlantic collaboration.

Want to know more?

If you have questions or want more information about this innovation mission, please contact us.